Skip to main content

Table 2 Treatment modalities of COPD patients

From: Value of serum and induced sputum surfactant protein-D in chronic obstructive pulmonary disease

  Group 2 (stage 1 and 2 COPD patients) Group 3 (stage 3 and 4 COPD patients)
  (n = 20) (n = 20)
Short acting β2 agonist 6 12
Long acting β2 agonist 12 18
Long acting anticholinergic 7 15
Inhaler steroid 6 18
N-acetyl systein 2 7
Long term oxygen therapy 2 10
Pulmoner rehabilitation 0 7